Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Historical Holders from Q3 2020 to Q1 2025

Symbol
RLAY on Nasdaq
CUSIP
75943R102
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
170M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
164M
Holdings value
$675M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
196
Number of buys
116
Number of sells
-70
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.1% -30% $27M -$11.4M 10.3M -29.8% BlackRock, Inc. Mar 31, 2025
Point72 Asset Management, L.P. 5.7% $25.4M 9.69M Point72 Asset Management, L.P. Mar 14, 2025

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 515K $1.35M +$60.7K $2.62 14
2024 Q4 164M $675M -$17.9M $4.12 196
2024 Q3 157M $1.11B +$213M $7.08 192
2024 Q2 127M $826M -$18.8M $6.52 171
2024 Q1 129M $1.07B -$15.2M $8.30 180
2023 Q4 127M $1.4B -$1.3M $11.01 175
2023 Q3 129M $1.08B -$1.94M $8.41 167
2023 Q2 128M $1.6B -$46.6M $12.56 157
2023 Q1 131M $2.15B +$54.4M $16.47 151
2022 Q4 128M $1.91B +$47.8M $14.94 158
2022 Q3 123M $2.76B +$23.7M $22.37 149
2022 Q2 121M $2.02B +$125M $16.75 133
2022 Q1 113M $3.38B +$65.3M $29.93 130
2021 Q4 110M $3.39B +$590M $30.71 126
2021 Q3 91.2M $2.88B +$72.5M $31.53 130
2021 Q2 88.6M $3.24B +$135M $36.59 121
2021 Q1 85.5M $2.95B -$171M $34.57 132
2020 Q4 87.3M $3.63B -$127M $41.56 111
2020 Q3 84.6M $3.6B +$3.6B $42.59 93